(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Pedal Power: Divulging Well known Bike Brands for Each Cyclist - 2An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Youngsters
- 3A Concise History Of The Entertainment world
- 4When preventable infections turn deadly behind bars | The Excerpt
- 5Vote in favor of the field action that revives your psyche and soul!
- Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- From School Dropout to Example of overcoming adversity: My Excursion
- Appreciate the World: Notable Caf\u00e9s You Want to Attempt
- Help Your Business with Master Web based Promoting Arrangements
- A Manual for Nations with Extraordinary Food
- Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
- Jamaica reports deadly leptospirosis outbreak after Hurricane Melissa
- A Republican elected governor in California? It's not as far-fetched as it sounds.
- Vote in favor of the pasta that makes good dieting charming!
